CR1 in Alzheimer's disease.

Abstract

The complement component receptor 1 gene (CR1), which encodes a type-I transmembrane glycoprotein, has recently been identified as one of the most important risk genes for late-onset Alzheimer's disease (LOAD). In this article, we reviewed the recent evidence concerning the role of CR1 in LOAD. First, we introduced the structure, localization and physiological function of CR1 in humans. Afterward, we summarized the relation of CR1 polymorphisms with LOAD risk. Finally, we discussed the possible impact of CR1 on the pathogenesis of AD including amyloid-β pathology, tauopathy, immune dysfunction and glial-mediated neuroinflammation. We hope that a more comprehensive understanding of the role that CR1 played in AD may lead to the development of novel therapeutics for the prevention and treatment of AD.

• Authors: Xi-Chen Zhu, Jin-Tai Yu, Teng Jiang, Ping Wang, Lei Cao, Lan Tan
• Journal: Molecular neurobiology (Mol Neurobiol) Vol. 51 Issue 2 Pg. 753-65 (Apr 2015) ISSN: 1559-1182 [Electronic] United States
• PMID: 24794147 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)

Chemical References

• CR1 protein, human
• Receptors, Complement 3b

Topics

• Alzheimer Disease (diagnosis, genetics)
• Animals
• Case-Control Studies
• Genetic Predisposition to Disease (genetics)
• Humans
• Polymorphism, Single Nucleotide (genetics)
• Receptors, Complement 3b (genetics)